| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18834319 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 108 journal articles in the PubMed database | Email to a friend | | |
| Liu CH, Liu CJ, Lin CL, et al.
Pegylated Interferon-alpha-2a plus Ribavirin for Treatment-Naive Asian Patients with Hepatitis C Virus Genotype 1 Infection: A Multicenter, Randomized Controlled Trial. [JOURNAL ARTICLE]
Clin Infect Dis 2008 Oct 3.
Abstract | Full Citation | Find Related Articles | | Yu JW, Wang GQ, Sun LJ, et al.
Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin. [Journal Article]
J Gastroenterol Hepatol 2007 Jun; 22(6):832-6.
Abstract | Full Citation | Find Related Articles | | Yamada G, Iino S, Okuno T, et al.
Virological Response in Patients with Hepatitis C Virus Genotype 1b and a High Viral Load : Impact of Peginterferon-alpha-2a plus Ribavirin Dose Reductions and Host-Related Factors. [Journal Article]
Clin Drug Investig 2008; 28(1):9-16.
Abstract | Full Citation | Find Related Articles | | Han Q, Liu Z, Kang W, et al.
Interferon Beta 1a versus Interferon Beta 1a plus Ribavirin for the Treatment of Chronic Hepatitis C in Chinese Patients: A Randomized, Placebo-Controlled Trial. [JOURNAL ARTICLE]
Dig Dis Sci 2007 Dec 13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Martin-Carbonero L, Nuñez M, Mariño A, et al.
Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C. [Journal Article, Research Support, Non-U.S. Gov't]
AIDS 2008 Jan 2; 22(1):15-21.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Shiffman ML, Suter F, Bacon BR, et al.
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3. [Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
N Engl J Med 2007 Jul 12; 357(2):124-34.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Jensen DM, Morgan TR, Marcellin P, et al.
Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy. [Journal Article]
Hepatology 2006 May; 43(5):954-60.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Mangia A, Ricci GL, Persico M, et al.
A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Viral Hepat 2005 May; 12(3):292-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Chung RT, Andersen J, Volberding P, et al.
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
N Engl J Med 2004 Jul 29; 351(5):451-9.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
